Terms ending in 2038
Every in-force patent on Bayer AG's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,350,633 | Coniothyrium Minitans for Protection of Cultivated Plants from Attacks by Fungal Pathogens Belonging to the Genus Phoma SPP. or Verticillium SPP. In force · High confidence | Danstar Ferment AG | In force | High confidence | |
| US 11,969,582 | Syringe Plunger With Dynamic Seal In force · High confidence | Bayer Healthcare LLC | In force | High confidence | |
| US 11,142,522 | Compounds, Compositions and Methods for Cancer Treatment In force · High confidence | Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 11,795,164 | 2-Heteroaryl-3-OXO-2,3-Dihydropyridazine-4-Carboxamides for the Treatment of Cancer In force · Medium confidence | Deutsches Krebsforschungszentrum | In force | Medium confidence | |
| US 12,522,594 | 2-Heteroaryl-3-OXO-2,3-Dihydropyridazine-4-Carboxamides for the Treatment of Cancer In force · Medium confidence | Deutsches Krebsforschungszentrum | In force | Medium confidence | |
| US 11,339,155 | 2-(HET)ARYL-SUBSTITUTED Fused Bicyclic Heterocycle Derivatives as Pesticides In force · High confidence | Bayer CropScience Aktiengesellschaft and Bayer Aktiengesellschaft | In force | High confidence | |
| US 11,058,115 | Heterocycle Derivatives as Pesticides In force · High confidence | Bayer Aktiengesellschaft and Bayer CropScience Aktiengesellschaft | In force | High confidence | |
| US 11,083,199 | Heterocycle Derivatives as Pesticides In force · High confidence | Bayer Aktiengesellschaft and Bayer CropScience Aktiengesellschaft | In force | High confidence | |
| US 11,419,334 | Method of Promoting Plant Growth Effects In force · High confidence | Bayer Aktiengesellschaft and Bayer CropScience Aktiengesellschaft | In force | High confidence | |
| US 11,439,713 | Method for Creating a Renal Injury Model to Screen Molecules for the Treatment of Renal Injury In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| 53 more term ends in 2038 · Pro | |||||
10 of 63 patents shown. Soonest term end first, then patent number.
Pro members see all 63.
50 of these are in force and held by Bayer AG.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.